CALX vs. MNPR
Compare and contrast key facts about Calix, Inc. (CALX) and Monopar Therapeutics Inc. (MNPR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CALX or MNPR.
Key characteristics
| CALX | MNPR | |
|---|---|---|
| YTD Return | -13.62% | 853.53% |
| 1Y Return | 14.50% | 702.48% |
| 3Y Return (Ann) | -15.57% | -12.31% |
| Sharpe Ratio | 0.36 | 0.95 |
| Sortino Ratio | 0.72 | 8.00 |
| Omega Ratio | 1.12 | 2.04 |
| Calmar Ratio | 0.24 | 6.11 |
| Martin Ratio | 0.78 | 14.04 |
| Ulcer Index | 19.70% | 43.09% |
| Daily Std Dev | 43.30% | 635.81% |
| Max Drawdown | -80.95% | -98.93% |
| Current Drawdown | -52.81% | -87.99% |
Fundamentals
| CALX | MNPR | |
|---|---|---|
| Market Cap | $2.60B | $62.29M |
| EPS | -$0.28 | -$2.30 |
| Total Revenue (TTM) | $689.18M | $0.00 |
| EBITDA (TTM) | -$7.79M | -$5.42M |
Correlation
The correlation between CALX and MNPR is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CALX vs. MNPR - Performance Comparison
In the year-to-date period, CALX achieves a -13.62% return, which is significantly lower than MNPR's 853.53% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CALX vs. MNPR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Calix, Inc. (CALX) and Monopar Therapeutics Inc. (MNPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CALX vs. MNPR - Dividend Comparison
Neither CALX nor MNPR has paid dividends to shareholders.
Drawdowns
CALX vs. MNPR - Drawdown Comparison
The maximum CALX drawdown since its inception was -80.95%, smaller than the maximum MNPR drawdown of -98.93%. Use the drawdown chart below to compare losses from any high point for CALX and MNPR. For additional features, visit the drawdowns tool.
Volatility
CALX vs. MNPR - Volatility Comparison
The current volatility for Calix, Inc. (CALX) is 9.95%, while Monopar Therapeutics Inc. (MNPR) has a volatility of 213.90%. This indicates that CALX experiences smaller price fluctuations and is considered to be less risky than MNPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CALX vs. MNPR - Financials Comparison
This section allows you to compare key financial metrics between Calix, Inc. and Monopar Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities